BioCentury
BioCentury
YouTubeLinkedInXRSS
ARTICLE | Distillery Therapeutics

Increasing AGXT expression to treat atherosclerosis

By biocentury Staff
August 27, 2021 8:26 PM UTC

DISEASE CATEGORY: Cardiovascular

INDICATION: Atherosclerosis...

BCIQ Company Profiles

University of Michigan

BCIQ Target Profiles

Alanine-glyoxylate aminotransferase (AGXT)

Chemokine CC motif ligand 5 (RANTES) (CCL5)

Monocyte chemoattractant protein-1 (MCP-1) (CCL2)

BCIQ Company Profiles

University of Michigan

BCIQ Target Profiles

Alanine-glyoxylate aminotransferase (AGXT)

Chemokine CC motif ligand 5 (RANTES) (CCL5)

Monocyte chemoattractant protein-1 (MCP-1) (CCL2)

About BioCentury

Privacy & Legal

Contact

About BioCentury

Company Overview
Management
Editorial & Research
Scientific Advisory Board

Privacy & Legal

User Agreement
Terms of Use
Privacy Policy
Use of Images & Market Data
Reprints & Permissions

Contact

Contact Us
Advertising & Sponsorship
Customer Resource Center
Career Opportunities
Forgot Password
YouTubeLinkedInXRSS
BioCentury
© 2025 BioCentury Inc. All Rights Reserved.
Copyright © 2025 BioCentury Inc. All Rights Reserved.
YouTubeLinkedInXRSS